Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJM (3) Autor Bertoletti,A (1) El-Mashad,Noha (1) Foad,Mona F (1) Lemes,Raquel M.L. (1) Lucca,HRL (1) Lyon,Juliana P. (1) Melhem,MSC (1) Meneghin,FA (1) Moreira,Leonardo M. (1) Resende,Maria Aparecida de (1) Salem,Dalia A. (1) Saudy,Niveen (1) Silva,RBO (1) Szeszs,MW (1) Mais... Palavra-chave CLSI (3) Antifungal agents (1) Antifungal drugs (1) Candida (1) Disk diffusion (1) E-test (1) EUCAST (1) Flowcytometry (1) Fluconazole (1) MIC (1) Malignant patients (1) NCCLS (1) Susceptibility testing methods (1) Trichosporon spp (1) Mais... Tipo do documento Info:eu-repo/semantics/article (3) Ano 2013 (1) 2012 (1) 2010 (1) País Brazil (3) Idioma Inglês (3)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 3 Primeira ... 1 ... Última Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies BJM Lemes,Raquel M.L.; Lyon,Juliana P.; Moreira,Leonardo M.; Resende,Maria Aparecida de. The aim of the present study was to evaluate the antifungal susceptibility profile of Trichosporon species isolated from different sources employing the Clinical and Laboratory Standards Institute (CLSI) method and E-test method. Thirty-four isolates of Trichosporon spp. and six CBS reference samples were tested for their susceptibility to Amphotericin B, 5-flucytosine, Fluconazole, Itraconazole, Voriconazole and Terbinafine. All species showed high Minimun Inhibitory Concentrations (MIC) for Itraconazole and susceptibility to Fluconazole, The comparison among the results obtained by the CLSI method and E-test revealed larger discrepancies among 5-flucytosine and Itraconazole. The present work provides epidemiological data that could influence therapeutic... Tipo: Info:eu-repo/semantics/article Palavras-chave: Trichosporon spp; Antifungal drugs; CLSI; E-test. Ano: 2010 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822010000200008 Susceptibility tests of oropharyngeal Candida albicans from Egyptian patients to fluconazole determined by three methods BJM El-Mashad,Noha; Foad,Mona F; Saudy,Niveen; Salem,Dalia A.. Candida albicans frequently cause oropharyngeal candidiasis in immunocompromised patients. As some of these isolates show resistance against azoles, the clinician is wary of initiating therapy with fluconazole (FZ) until a final susceptibility report is generated. We aimed to evaluate the efficacy of rapid flow cytometry (FCM) and disc diffusion (DD) methods in comparison to reference microdilution (MD) of Clinical and Laboratory Standards Institute (CLSI) method for FZ. Thirty seven Candida albicans isolates were tested by the three methods. By both MD and FCM, 26/37 (70.3%) were sensitive with minimal inhibitory concentration (MIC) ≤ 8μg/ml, 5/37 (13.5%) were susceptible dose dependant (S-DD) with MIC 16-32 μg/ml and 6/37 (16.2%) were resistant with MIC... Tipo: Info:eu-repo/semantics/article Palavras-chave: CLSI; Disk diffusion; Flowcytometry; Fluconazole; Malignant patients; NCCLS. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822012000100031 Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species BJM Melhem,MSC; Bertoletti,A; Lucca,HRL; Silva,RBO; Meneghin,FA; Szeszs,MW. Eleven quality control isolates (Candida albicans ATCC 64548, C. tropicalis ATCC 200956, C. glabrata ATCC 90030, C. lusitaniae ATCC 200951, C. parapsilosis ATCC 22019, C. krusei ATCC 6258, C. dubliniensis ATCC 6330, Saccharomyces cerevisiae ATCC 9763, Cryptococcus neoformans ATCC 90012, C. gattii FIOCRUZ-CPF 60, and Trichosporon mucoides ATCC 204094) and 32 bloodstream isolates, including C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, C. krusei, C. guilliermondii, C. pelliculosa (Pichia anomala), C. haemulonii, C. lusitaniae, and C. kefyr were identified at the species level by the VITEK 2 system. A set of clinical isolates (32 total) were used as challenge strains to evaluate the ability of the VITEK 2 system to determine the antifungal... Tipo: Info:eu-repo/semantics/article Palavras-chave: Antifungal agents; Candida; Susceptibility testing methods; MIC; CLSI; EUCAST. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000400033 Registros recuperados: 3 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco